Ixia Pharmaceutical Limited - Company Profile

It is a pharma public limited company based in Varanasi, Uttar Pradesh, India, established in 2021.
2021 Varanasi, Uttar Pradesh, India Active
Last Updated:
Access Report
About Ixia Pharmaceutical Limited

Ixia Pharmaceutical Limited, a active public limited company, was established on 23 July 2021 in Varanasi, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24110UP2021PLC149392. Registered under ROC Roc Uttar Pradesh I. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Krishna Devi (Director), Puja Singh (Director), Sudhir Kumar (Additional Director). Past directors included Jyoti Kumari, Sudhir Kumar. It is based at E-16, Vishwakarma Nagar Colony Susuwahi, Varanasi, Uttar Pradesh, 221005.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110UP2021PLC149392

  • Registration Number

    149392

  • Incorporation Date

    23 July 2021

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Uttar Pradesh I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 4 Year, 7 Months
Company report

Ixia Pharmaceutical Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ixia Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ixia Pharmaceutical Limited?
Current Directors
Name Designation Appointment Date Status
Krishna Devi Director 23 Jul 2021 Current
Puja Singh Director 23 Jul 2021 Current
Sudhir Kumar Additional Director 25 Sep 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 27 Sep 2021 Past
Pramod Abcsdd Director 05 Sep 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ixia Pharmaceutical.

Enhance accessibility to Ixia Pharmaceutical's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Ixia Pharmaceutical revenue growth over time
Ixia Pharmaceutical profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ixia Pharmaceutical?

Unlock access to Ixia Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ixia Pharmaceutical?

Ixia Pharmaceutical has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ixia Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ixia Pharmaceutical's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ixia Pharmaceutical
Recent Activity within the Organization
  • Director Appointment

    Sudhir Kumar was appointed as a Additional Director was appointed as a Additional Director on 25 Sep 2021 & has been associated with this company since 4 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Krishna Devi was appointed as a Director was appointed as a Director on 23 Jul 2021 & has been associated with this company since 4 years 7 months . was completed.

  • Director Appointment

    The activity Puja Singh was appointed as a Director was appointed as a Director on 23 Jul 2021 & has been associated with this company since 4 years 7 months . was completed.

  • Company Incorporation

    Progress on Ixia Pharmaceutical Limited was registered on 23 Jul 2021 with Roc Uttar Pradesh I & aged 4 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ixia Pharmaceutical Limited?

The CIN of Ixia Pharmaceutical Limited is U24110UP2021PLC149392.

Where is Ixia Pharmaceutical Limited headquartered?

Ixia Pharmaceutical Limited is headquartered at E-16, Vishwakarma Nagar Colony Susuwahi, Varanasi, Uttar Pradesh, 221005.

When was Ixia Pharmaceutical Limited incorporated?

Ixia Pharmaceutical Limited was incorporated on 23 July 2021.

Who are the current directors of Ixia Pharmaceutical Limited?

The current directors of Ixia Pharmaceutical Limited are

What is the primary industry of Ixia Pharmaceutical Limited?

The primary industry of Ixia Pharmaceutical Limited is Pharma.

Is Ixia Pharmaceutical Limited a listed company?

Ixia Pharmaceutical Limited is unlisted.

What is the capital structure of Ixia Pharmaceutical Limited?

The authorized capital of Ixia Pharmaceutical Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available